UNION CITY, Calif.,
July 13, 2016 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company
manufacturing point-of-care blood analysis instruments and
consumables for the medical and veterinary markets worldwide, has
scheduled a conference call to discuss its financial results for
the first quarter fiscal year 2017, ended June 30, 2016. The call will be at 4:15 p.m. ET on Thursday,
July 21, 2016. The Company will report financial
results for the first quarter fiscal year 2017 after the market
closes on Thursday, July 21,
2016.
Participants can dial (844) 855-9498 or (412) 317-5496 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code
10089674, through July 28, 2016.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer
of portable blood analysis systems that are used in a broad range
of medical specialties in human or veterinary patient care to
provide clinicians with rapid blood constituent measurements.
Our mission is to improve the efficiency of care delivery to and
the quality of life of patients in the medical and veterinary
markets. We provide leading edge technology and tools that
support best medical practices, enabling physicians and
veterinarians to respond to the health needs of their clients at
the point of care while operating economical and profitable
practices. For more information, visit
http://www.abaxis.com
|
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert
Blum
|
|
Abaxis,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abaxis-to-report-first-quarter-fiscal-year-2017-financial-results-on-thursday-july-21-2016-300297833.html
SOURCE Abaxis, Inc.